Refractory Schizophrenia

Neurology
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
repetitive Transcranial Magnetic StimulationN/A3 trials
Active Trials
NCT00699218Completed15Est. Apr 2010
NCT00517075Terminated14Est. Jun 2011
NCT01386918Completed144Est. Jan 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance Pharmaceuticalsrepetitive Transcranial Magnetic Stimulation
Alliance Pharmaceuticalsrepetitive Transcranial Magnetic Stimulation
Alliance Pharmaceuticalsrepetitive Transcranial Magnetic Stimulation

Clinical Trials (3)

Total enrollment: 173 patients across 3 trials

NCT00517075Alliance Pharmaceuticalsrepetitive Transcranial Magnetic Stimulation

Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)

Start: Sep 2004Est. completion: Jun 201114 patients
Phase 2Terminated
NCT00699218Alliance Pharmaceuticalsrepetitive Transcranial Magnetic Stimulation

A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression

Start: May 2008Est. completion: Apr 201015 patients
N/ACompleted
NCT01386918Alliance Pharmaceuticalsrepetitive Transcranial Magnetic Stimulation

Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia

Start: Feb 2004Est. completion: Jan 2009144 patients
N/ACompleted

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
12h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
12h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
13h ago

Director of Finance

CoMind
London, UK
13h ago

Electronics Engineering Manager

CoMind
London, UK
13h ago

Director of Information Technology

Zavation Medical Products
13h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Epilepsy(296)Multiple Sclerosis(283)Schizophrenia(268)Parkinson Disease(185)Alzheimer's Disease(179)Parkinson's Disease(163)Alzheimer Disease(119)Stroke(102)Depression(84)Relapsing-Remitting Multiple Sclerosis(84)